AstraZeneca, Mylan Spar Over Prilosec Suit Dismissal
By Christopher Norton ( March 7, 2011, 4:51 PM EST) -- AstraZeneca AB and Mylan Laboratories Inc. squared off before the Federal Circuit on Monday over whether a district judge wrongly dismissed Mylan's allegations that AstraZeneca violated antitrust law by filing sham patent suits to protect its heartburn drug Prilosec....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.